These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 8377095)

  • 21. Impact of simulating borderline personality disorder on the MMPI-2: a costs-benefits model employing base rates.
    Sivec HJ; Hilsenroth MJ; Lynn SJ
    J Pers Assess; 1995 Apr; 64(2):295-311. PubMed ID: 7722855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detecting symptom exaggeration in combat veterans using the MMPI-2 symptom validity scales: a mixed group validation.
    Tolin DF; Steenkamp MM; Marx BP; Litz BT
    Psychol Assess; 2010 Dec; 22(4):729-36. PubMed ID: 21038968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MMPI-2 profile code types and measurement error.
    Munley PH; Germain JM; Tovar-Murray D; Borgman AL
    J Pers Assess; 2004 Apr; 82(2):179-88. PubMed ID: 15041524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MMPI-A validity scale uses and limitations in detecting varying levels of random responding.
    Archer RP; Handel RW; Lynch KD; Elkins DE
    J Pers Assess; 2002 Jun; 78(3):417-31. PubMed ID: 12146812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of two MMPI-2 validity scales on basic scale relations to external criteria.
    Archer RP; Fontaine J; McCrae RR
    J Pers Assess; 1998 Feb; 70(1):87-102. PubMed ID: 9615425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Examining the potential for gender bias in the prediction of symptom validity test failure by MMPI-2 symptom validity scale scores.
    Lee TT; Graham JR; Sellbom M; Gervais RO
    Psychol Assess; 2012 Sep; 24(3):618-27. PubMed ID: 22309000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of MMPI-2 on scoring of special scales derived from MMPI-1.
    Levitt EE; Browning JM; Freeland LJ
    J Pers Assess; 1992 Aug; 59(1):22-31. PubMed ID: 1512678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The utility of the NEO-PI-R validity scales to detect response distortion: a comparison with the MMPI-2.
    Morasco BJ; Gfeller JD; Elder KA
    J Pers Assess; 2007 Jun; 88(3):276-83. PubMed ID: 17518549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevation differences between MMPI-2 clinical and restructured clinical (RC) scales: frequency, origins, and interpretative implications.
    Sellbom M; Ben-Porath YS; McNulty JL; Arbisi PA; Graham JR
    Assessment; 2006 Dec; 13(4):430-41. PubMed ID: 17050913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of psychopathology and demographic characteristics on MMPI-2 scale scores.
    Schinka JA; LaLone L; Greene RL
    J Pers Assess; 1998 Apr; 70(2):197-211. PubMed ID: 9697327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The MMPI-2 in Perú: a normative study.
    Scott RL; Pampa WM
    J Pers Assess; 2000 Feb; 74(1):95-105. PubMed ID: 10779935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MMPI-2 in the inpatient assessment of women with eating disorders.
    Cumella EJ; Wall AD; Kerr-Almeida N
    J Pers Assess; 2000 Dec; 75(3):387-403. PubMed ID: 11117153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interpretation of a full-information item-level factor analysis of the MMPI-2: normative sampling and nonpathognomonic descriptors.
    Leonelli BT; Chang CH; Bock RD; Schilling SG
    J Pers Assess; 2000 Jun; 74(3):400-22. PubMed ID: 10900568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Faking bad and faking good by college students on the Korean MMPI-2.
    Hahn J
    J Pers Assess; 2005 Aug; 85(1):65-73. PubMed ID: 16083385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of the MCMI-III personality disorder and modifier indices with the MMPI-2 clinical and validity scales.
    Schoenberg MR; Dorr D; Morgan CD; Burke M
    J Pers Assess; 2004 Jun; 82(3):273-80. PubMed ID: 15151803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychometric evaluation of the MMPI-2 Restructured Clinical scales in two Dutch samples.
    van der Heijden PT; Egger JI; Derksen JJ
    J Pers Assess; 2008 Sep; 90(5):456-64. PubMed ID: 18704804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Examining the impact of unscorable item responses on the validity and interpretability of MMPI-2/MMPI-2-RF Restructured Clinical (RC) Scale scores.
    Dragon WR; Ben-Porath YS; Handel RW
    Assessment; 2012 Mar; 19(1):101-13. PubMed ID: 21835886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Graying of the critical items: effects of aging on responding to MMPI-2 critical items.
    Aaronson AL; Dent OB; Webb JT; Kline CD
    J Pers Assess; 1996 Feb; 66(1):169-76. PubMed ID: 8576830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of overreported psychopathology with the MMPI-2-RF [corrected] validity scales.
    Sellbom M; Bagby RM
    Psychol Assess; 2010 Dec; 22(4):757-67. PubMed ID: 21133544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validity of the substance abuse scales of the MMPI-2 in a college student sample.
    Svanum S; McGrew J; Ehrmann L
    J Pers Assess; 1994 Jun; 62(3):427-39. PubMed ID: 8027909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.